Chronic obstructive pulmonary disease
Conditions
Interventions
treatment group 1:Bufei particles
treatment group 2:Bufei particles and placebo
Sponsors
Second affiliated hospital of Tianjin University of TCM
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) In line with the western medicine diagnostic criteria for chronic obstructive pulmonary disease (COPD); (2) Clinical severity of pulmonary function in COPD class II in (medium) and III (smi) standard; (3) Conform to the Chinese medicine lung spleen kidney deficiency, phlegm and blood stasis and syndrome differentiation standard each; (4) Illness is a plateau; (5) Aged 40-75 years old; (6) Patients did not attend other drug clinical research in the recent month; (7) Volunteered to accept this kind of treatment, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Diagnosed with COPD, but belongs to the acute aggravating period; (2) Diagnosed with COPD, but the chest X-ray or chest CT tips such as bronchiectasis disease, cystic fibrosis, tuberculosis fibrosis lesions, lung diffuse suffused with bronchiolitis and occlusive bronchiolitis and bronchial asthma and other chronic respiratory diseases; (3) Diagnosed with COPD, but not belong to the clinical severity of COPD lung function class II in (medium) and III (smi) standards; (4) Do not conform to the diagnostic criteria of TCM and western medicine; (5) Use the invigorating lung and kidney TCM or other enhance immune drugs before into the group one month ago; (6) Pregnancy and preparation of pregnancy women, lactation women; (7) Allergies or allergic to medicines; (8) With serious primary diseases of cardiovascular, liver, kidney and hematopoietic system, etc; (9) Psychotic disorders or other reasons can't cooperate with treatment; (10) Included in the standard but not signing the informed consent and voluntary entrants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency and duration of AECOPD;Lung function;The routine blood text; | — |
Secondary
| Measure | Time frame |
|---|---|
| SLEFI;The six-minute walking distance;the score of CAT;The score of BODE;Determination of treg cells and thl7 cell; | — |
Countries
China
Contacts
Public ContactSun Zeng Tao
Second affiliated hospital of Tianjin University of TCM
Outcome results
None listed